EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug Delivery Systems Based on Metal–Organic Frameworks for Tumor Immunotherapy

Ning Yang, Zongyan He, Tianqun Lang iD

Pharmaceutics · 10.02.2025 · 17 (2) · 225

DOI: 10.3390/pharmaceutics17020225 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 10.02.2025. Verfasst von Ning Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lin Gang Laboratory, Shanghai 200031, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Post-doctoral Excellence Program, "Science and Technology Innovation Action Plan" Sailing Plan of Shanghai, “Science and Technology Innovation Action Plan” Sailing Plan of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal–organic frameworks (MOFs) are a class of inorganic-organic hybrid nanoparticles formed by the coordination of metal ions/clusters and organic ligands. Due to their high porosities, large surface areas, adjustable structures, and responsiveness to light/sound, etc., MOFs have shown great clinical potential in the field of tumor therapy. Tumor immunotherapy exerts antitumor effects through reshaping tumor immune microenvironment, showing significant preclinical and clinical advantages. Based on the mechanisms of immunity activation, the tumor immunotherapy agents can be divided into chemotherapeutic agents, immunomodulators, enzymes, tumor vaccines and oligonucleotide drugs, etc. Herein, we review the MOFs-based drug delivery systems for tumor immunotherapy. The classification of MOFs, followed by their antitumor immunity activation mechanisms, are first introduced. Drug delivery systems based on MOFs with different immunotherapy agents are also summarized, especially the synergetic immunity activation mechanisms triggered by MOFs and their loadings. Furthermore, the merits and drawbacks of MOFs and the potential strategies for MOFs to promote their clinical applications are discussed.

Schlagwörter

Stichwörter der Autor:innen

MOFsdrug deliverytumor immunotherapy

Autor:innen und Institutionen

  • Lin Gang Laboratory, Shanghai 200031, China.

ORCID-Profile: Tianqun Lang

Förderung

  • Shanghai Post-doctoral Excellence Program
  • "Science and Technology Innovation Action Plan" Sailing Plan of Shanghai
  • “Science and Technology Innovation Action Plan” Sailing Plan of Shanghai

Zitieren

APA

Yang, N., He, Z., & Lang, T. (2025). Drug Delivery Systems Based on Metal–Organic Frameworks for Tumor Immunotherapy. Pharmaceutics, 17(2), 225. https://doi.org/10.3390/pharmaceutics17020225

Vancouver

Yang N, He Z, Lang T. Drug Delivery Systems Based on Metal–Organic Frameworks for Tumor Immunotherapy. Pharmaceutics. 2025;17(2):225. doi:10.3390/pharmaceutics17020225

BibTeX
@article{Yang2025,
  author = {Yang, Ning and He, Zongyan and Lang, Tianqun},
  title = {Drug Delivery Systems Based on Metal–Organic Frameworks for Tumor Immunotherapy},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {225},
  doi = {10.3390/pharmaceutics17020225}
}
Kostenlos starten →